Novo Nordisk
NVO
#109
Rank
NZ$293.77 B
Marketcap
NZ$66.04
Share price
-0.96%
Change (1 day)
-32.51%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report